Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Sickle Cell 101 Unveils Its Innovative Approach in Digital Advocacy for a 'Rare' Disorder Through Social Media
Via Newsfile
Exposures Product Safety
Jay Vics Interviews Ezralea Robbins of Mountainside Spa in Episode 44 of Meet the Experts Podcast
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
Clarius Announces the First FDA-Cleared AI Ultrasound Application for Musculoskeletal Imaging
Via Newswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
420 with CNW — FDA Publishes Final Guidance for Cannabis Drug Development
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis Product Safety
Tickers IGC
420 with CNW — FDA Publishes Final Guidance for Cannabis Drug Development
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
Tickers IGC
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures ~$8.4M in Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers NMRD
The Car Law Firm provides its service to deceived clients in automobile purchasing.
Via Get News
Topics Product Recall
Exposures Legal Product Safety
AgelessRx Announces the Availability of Acarbose to Block Starchy Carbs and Improve Weight Loss with Dieting and Medication
Via GetFeatured
Exposures Ethanol Product Safety
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
Via NewMediaWire
Exposures Product Safety
Tickers UEEC
Lexaria Bioscience: Charting a Path to Commercial Success
Via NewMediaWire
Exposures Product Safety
Tickers LEXX
Overnight Glasses Introduces A New Page Where They Gathered Every Information, Resource, And Online Feature One Might Need When Buying Eyeglasses Online
Via Magic PR
Exposures Product Safety
Glint Pharmaceuticals Receives FDA IND Acceptance for Clinical Study for Phase 1/2 Clinical Trial of Antibiotic Drug-Releasing Contact Lens, ACL5
Via 24-7 Press Release
Exposures Product Safety
ZetrOZ Systems to Attend and Present at the Big Sky Athletic Training Sports Medicine Conference
Via Newswire.com
Exposures Product Safety
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Commences Recruitment in FSD201 Phase 2 Clinical Trial
Via Investor Brand Network
Exposures Product Safety
Tickers CSE:HUGE HUGE
Immediate Therapy for Urinary Incontinence in Women
Via PRLog
Exposures Product Safety
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Via MarketBeat
Exposures Product Safety
Tickers AZN BIIB LLY MRK
TOP RANKED ROSEN LAW FIRM Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers YMAB
Dell Laser Consultants Announces Treatment of First Patient in Austin With the IC-8® Apthera™ IOL
Via Newswire.com
Exposures Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers NMRD
Ainnova Tech announces Dr. Maziar Lalezary, M.D. as Medical advisor and member of Medical Board
Via Zexprwire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
Via Newsfile
Exposures Product Safety
Tickers SKYE
cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News
Via Newsfile
Exposures Product Safety
Tickers YCBD
YMAB NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers YMAB
Report on 63 FDA-Approved Brand Names Released by Branding Agency, Brandsymbol
Via Press Advantage
Exposures Product Safety
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
Via FinancialNewsMedia
Exposures Product Safety
Tickers CSE:LOBE LOBEF
Mergers and Acquisitions in 2023 Off To A Strong Start
Via MarketBeat
Exposures Product Safety
Tickers AZN BNTX CVS GILD
How Could GSK's RSV Vaccine Change its Valuation?
Via MarketBeat
Exposures Product Safety
Tickers GSK MRNA PFE
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Advances Novel Drug Candidate in Treating Alzheimer’s Symptoms
Via Investor Brand Network
Exposures Product Safety
Tickers IGC
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
Via MarketBeat
Topics Workforce
Exposures Layoff Product Safety
Tickers EDIT ELEV FATE IPSC
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Doses First Participants in PH10 Phase 1 Clinical Trial
Via Investor Brand Network
Exposures Product Safety
Tickers VTGN
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.